# Bupivacaine Liposome Suspension Versus a Concentrated Multi Drug Periarticular Injection

> **NCT02299349** · NA · COMPLETED · sponsor: **TriHealth Inc.** · enrollment: 70 (actual)

## Conditions studied

- Total Knee Arthroplasty

## Interventions

- **DRUG:** bupivacaine liposome suspension
- **DRUG:** concentrated multi drug Ketorlac, Morphine PF, Epinephrine, Ropivicaine, 0.9% NaCL

## Key facts

- **NCT ID:** NCT02299349
- **Lead sponsor:** TriHealth Inc.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2013-12
- **Final completion:** 2014-03
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2018-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02299349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02299349, "Bupivacaine Liposome Suspension Versus a Concentrated Multi Drug Periarticular Injection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02299349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*